Literature DB >> 17699809

Laminin compensation in collagen alpha3(IV) knockout (Alport) glomeruli contributes to permeability defects.

Dale R Abrahamson1, Kathryn Isom, Eileen Roach, Larysa Stroganova, Adrian Zelenchuk, Jeffrey H Miner, Patricia L St John.   

Abstract

Alport disease is caused by mutations in genes encoding the alpha3, alpha4, or alpha5 chains of type IV collagen, which form the collagenous network of mature glomerular basement membrane (GBM). In the absence of alpha3, alpha4, alpha5 (IV) collagen, alpha1, alpha2 (IV) collagen persists, which ordinarily is found only in GBM of developing kidney. In addition to dysregulation of collagen IV, Alport GBM contains aberrant laminins, which may contribute to the progressive GBM thickening and splitting, proteinuria, and renal failure seen in this disorder. This study sought to characterize further the laminin dysregulation in collagen alpha3(IV) knockout mice, a model of Alport disease. With the use of confocal microscopy, laminin alpha1 and alpha5 abundance was quantified, and it was found that they co-distributed in significantly large amounts in areas of GBM thickening. In addition, labeling of entire glomeruli for laminin alpha5 was significantly greater in Alport mice than in wild-type siblings. Reverse transcriptase-PCR from isolated glomeruli demonstrated significantly more laminin alpha5 mRNA in Alport mice than in wild-type controls, indicating upregulated transcription of Lama5. For testing glomerular barrier function, ferritin was injected into 2-wk-old Alport and control mice, and GBM was examined by electron microscopy. Highest ferritin levels were seen in Alport GBM thickenings beneath effaced podocyte foot processes, but morphologically normal GBM was significantly permeable as well. We concluded that (1) ultrastructurally normal Alport GBM residing beneath differentiated podocyte foot processes is inherently and abnormally permeable, and (2) upregulation of Lama5 transcription and concentration of laminin alpha1 and alpha5 within Alport GBM thickenings contribute to abnormal permeabilities.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17699809     DOI: 10.1681/ASN.2007030328

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  35 in total

Review 1.  Ocular features in Alport syndrome: pathogenesis and clinical significance.

Authors:  Judy Savige; Shivanand Sheth; Anita Leys; Anjali Nicholson; Heather G Mack; Deb Colville
Journal:  Clin J Am Soc Nephrol       Date:  2015-02-03       Impact factor: 8.237

2.  Solute partitioning and filtration by extracellular matrices.

Authors:  William H Fissell; Christina L Hofmann; Nicholas Ferrell; Lisa Schnell; Anna Dubnisheva; Andrew L Zydney; Peter D Yurchenco; Shuvo Roy
Journal:  Am J Physiol Renal Physiol       Date:  2009-07-08

3.  Deletion of von Hippel-Lindau in glomerular podocytes results in glomerular basement membrane thickening, ectopic subepithelial deposition of collagen {alpha}1{alpha}2{alpha}1(IV), expression of neuroglobin, and proteinuria.

Authors:  Brooke M Steenhard; Kathryn Isom; Larysa Stroganova; Patricia L St John; Adrian Zelenchuk; Paul B Freeburg; Lawrence B Holzman; Dale R Abrahamson
Journal:  Am J Pathol       Date:  2010-06-03       Impact factor: 4.307

Review 4.  Complexities of the glomerular basement membrane.

Authors:  Richard W Naylor; Mychel R P T Morais; Rachel Lennon
Journal:  Nat Rev Nephrol       Date:  2020-08-24       Impact factor: 28.314

5.  Two Specific Sulfatide Species Are Dysregulated during Renal Development in a Mouse Model of Alport Syndrome.

Authors:  Megan M Gessel; Jeffrey M Spraggins; Paul A Voziyan; Dale R Abrahamson; Richard M Caprioli; Billy G Hudson
Journal:  Lipids       Date:  2019-06-13       Impact factor: 1.880

6.  Excess podocyte semaphorin-3A leads to glomerular disease involving plexinA1-nephrin interaction.

Authors:  Kimberly J Reidy; Pardeep K Aggarwal; Juan J Jimenez; David B Thomas; Delma Veron; Alda Tufro
Journal:  Am J Pathol       Date:  2013-08-14       Impact factor: 4.307

Review 7.  Collagen IV diseases: A focus on the glomerular basement membrane in Alport syndrome.

Authors:  Dominic Cosgrove; Shiguang Liu
Journal:  Matrix Biol       Date:  2016-08-27       Impact factor: 11.583

Review 8.  An update on the pathomechanisms and future therapies of Alport syndrome.

Authors:  Damien Noone; Christoph Licht
Journal:  Pediatr Nephrol       Date:  2012-08-18       Impact factor: 3.714

9.  Biomechanical strain causes maladaptive gene regulation, contributing to Alport glomerular disease.

Authors:  Daniel T Meehan; Duane Delimont; Linda Cheung; Marisa Zallocchi; Steven C Sansom; J David Holzclaw; Velidi Rao; Dominic Cosgrove
Journal:  Kidney Int       Date:  2009-08-26       Impact factor: 10.612

Review 10.  The glomerular basement membrane as a barrier to albumin.

Authors:  Jung Hee Suh; Jeffrey H Miner
Journal:  Nat Rev Nephrol       Date:  2013-06-18       Impact factor: 28.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.